These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10675697)

  • 1. Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats.
    Dahlin M; Björk E
    Int J Pharm; 2000 Feb; 195(1-2):197-205. PubMed ID: 10675697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative pharmacokinetic and pharmacodynamic study of the 5-HT1A receptor antagonist (S)-UH-301 in the rat.
    Yan H; Yu H; Lewander T
    Eur Neuropsychopharmacol; 2002 Apr; 12(2):101-10. PubMed ID: 11872325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer's disease to rats.
    Dahlin M; Björk E
    Int J Pharm; 2001 Jan; 212(2):267-74. PubMed ID: 11165084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic behavior in plasma, cerebrospinal fluid and cerebral cortex after intranasal administration of hydrochloride meptazinol.
    Shi Z; Zhang Q; Jiang X
    Life Sci; 2005 Sep; 77(20):2574-83. PubMed ID: 15993428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.
    Chow HS; Chen Z; Matsuura GT
    J Pharm Sci; 1999 Aug; 88(8):754-8. PubMed ID: 10430537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
    Charlton ST; Whetstone J; Fayinka ST; Read KD; Illum L; Davis SS
    Pharm Res; 2008 Jul; 25(7):1531-43. PubMed ID: 18293062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
    Yu H; Liu Y; Hacksell U; Lewander T
    J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus.
    Nomikos GG; Arborelius L; Svensson TH
    Eur J Pharmacol; 1992 Jun; 216(3):373-8. PubMed ID: 1425929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats.
    Wang Q; Chen G
    Biopharm Drug Dispos; 2009 Dec; 30(9):551-5. PubMed ID: 19780094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.
    Wang X; He H; Leng W; Tang X
    Int J Pharm; 2006 Jul; 317(1):40-6. PubMed ID: 16631329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of antihistamines into the CSF following intranasal delivery.
    Chou KJ; Donovan MD
    Biopharm Drug Dispos; 1997 May; 18(4):335-46. PubMed ID: 9158881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol in rat plasma and cerebrospinal fluid after intranasal administration.
    Zhao Y; Tao T; Wu J; Pi J; He N; Chai X; Chen Q
    J Pharm Pharmacol; 2008 Sep; 60(9):1149-54. PubMed ID: 18718117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
    Sakane T; Akizuki M; Yoshida M; Yamashita S; Nadai T; Hashida M; Sezaki H
    J Pharm Pharmacol; 1991 Jun; 43(6):449-51. PubMed ID: 1681064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT(1A) receptor active compounds (R)-8-OH-DPAT and (S)-UH-301 modulate auditory evoked EEG responses in rats.
    Stevens KE; O'Neill HC; Rose GM; Luthman J
    Amino Acids; 2006 Nov; 31(4):365-75. PubMed ID: 16868646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel 5-HT1A receptor antagonist (S)-UH-301 antagonizes 8-OH-DPAT-induced effects on male as well as female rat copulatory behaviour.
    Johansson CE; Meyerson BJ; Hacksell U
    Eur J Pharmacol; 1991 Sep; 202(1):81-7. PubMed ID: 1838499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.
    Sakane T; Akizuki M; Taki Y; Yamashita S; Sezaki H; Nadai T
    J Pharm Pharmacol; 1995 May; 47(5):379-81. PubMed ID: 7494186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of nimodipine in brain following intranasal administration in rats.
    Zhang QZ; Jiang XG; Wu CH
    Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
    Chow HH; Anavy N; Villalobos A
    J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.